![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DRAGON PHARMACEUTICAL ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2005
DRAGON PHARMACEUTICAL ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2005
September 22, 2005
Dragon Pharmaceutical Inc. ("Dragon" or the "Company") (TSX: DDD; OTC BB: DRUG) today announced the financial results for the second quarter of 2005. Due to Dragon's acquisition of Oriental Wave Holding Limited ("Oriental Wave") on January 12, 2005 being deemed a reverse take-over transaction, the following discussion reflects the Company's results of operations for the quarter ended June 30, 2005 while discussions on the quarter ended June 30, 2004 only reflect the results of Oriental Wave's Pharma and Chemical businesses.
Black Enterprise (http://www.blackenterprise.com/yb/ybopen.asp?section=ybbf&story_id=81939253&ID=blackenterprise)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct